Europe Neurovascular Devices Market Forecast to 2027 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Neurovascular Devices Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Neurovascular Devices Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Incidences of Neurovascular Diseases
5.1.2 Rising Demand for Minimally Invasive Procedures
5.1.3 Significantly Growing Aging Population

5.2 Market Opportunities

5.2.1 Development in the Healthcare Market
5.2.2 Lack of Expert Professionals

5.3 Future Trends

5.3.1 Enduring Clinical Trials for the Treatment of Stroke

5.4 Impact of Drivers and Restraints

6. Europe Neurovascular Devices Market Regional Analysis

6.1 Europe Neurovascular Devices Market Overview

6.2 Europe Neurovascular Devices Market Revenue 2017-2027 (US$ Million)

6.3 Europe Neurovascular Devices Market Forecast Analysis

7. Europe Neurovascular Devices Market Analysis – by Product

7.1 Neurothrombectomy Devices

7.1.1 Overview
7.1.2 Neurothrombectomy Devices: Europe Neurovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Aneurysm Coiling & Embolization Devices

7.2.1 Overview
7.2.2 Aneurysm Coiling & Embolization Devices: Europe Neurovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Cerebral Balloon Angioplasty & Stenting Systems and Support Devices

7.3.1 Overview
7.3.2 Cerebral Balloon Angioplasty & Stenting Systems and Support Devices: Europe Neurovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Neurovascular Devices Market Analysis – by Application

8.1 Cerebral Aneurysms

8.1.1 Overview
8.1.2 Cerebral Aneurysms: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Ischemic Strokes

8.2.1 Overview
8.2.2 Ischemic Strokes: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Arteriovenous Malformation & Fistulas

8.3.1 Overview
8.3.2 Arteriovenous Malformation & Fistulas: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Other Applications

8.4.1 Overview
8.4.2 Other Applications: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Neurovascular Devices Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Other Applications: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Ambulatory Surgical Centers

9.2.1 Overview
9.2.2 Other Applications: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Specialized Clinics

9.3.1 Overview
9.3.2 Other Applications: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Neurovascular Devices Market – Europe Analysis

10.1 Europe

10.1.1 Europe Neurovascular Devices Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 Europe Neurovascular Devices Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 UK: Europe Neurovascular Devices Market Breakdown, by Product
10.1.1.1.2 UK: Europe Neurovascular Devices Market Breakdown, by Application
10.1.1.1.3 UK: Europe Neurovascular Devices Market Breakdown, by End User

10.1.1.2 Germany: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Germany: Europe Neurovascular Devices Market Breakdown, by Product
10.1.1.2.2 Germany: Europe Neurovascular Devices Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Neurovascular Devices Market Breakdown, by End User

10.1.1.3 France: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 France: Europe Neurovascular Devices Market Breakdown, by Product
10.1.1.3.2 France: Europe Neurovascular Devices Market Breakdown, by Application
10.1.1.3.3 France: Europe Neurovascular Devices Market Breakdown, by End User

10.1.1.4 Russia: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Russia: Europe Neurovascular Devices Market Breakdown, by Product
10.1.1.4.2 Russia: Europe Neurovascular Devices Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Neurovascular Devices Market Breakdown, by End User

10.1.1.5 Italy: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.5.1 Italy: Europe Neurovascular Devices Market Breakdown, by Product
10.1.1.5.2 Italy: Europe Neurovascular Devices Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Neurovascular Devices Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Neurovascular Devices Market Breakdown, by Product
10.1.1.6.2 Rest of Europe: Europe Neurovascular Devices Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Neurovascular Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Neurovascular Devices Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Medtronic plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Johnson and Johnson, Inc (DePuy Synthes)

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Penumbra, Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Terumo Corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 MicroPort Scientific Corporation

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Integer Holdings Corporation

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Memry Corporation

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Phenox GmbH

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights